Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Liver Neoplasms × anlotinib × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Thyroid Neoplasms 2 Esophageal Neoplasms 2 Liver Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

Hepatectomy 8 Blood Specimen Collection 8 Sorafenib 5 Polymerase Chain Reaction 4 regorafenib 3 Mass Spectrometry 3 Liver Transplantation 3 Immunohistochemistry 3 Chemoembolization, Therapeutic 3 Biopsy 3 Surveys and Questionnaires 2 Magnetic Resonance Imaging 2 Gene Expression Profiling 2 trastuzumab deruxtecan 1 taxane 1 spartalizumab 1 sintilimab 1 lenvatinib 1 gadolinium ethoxybenzyl DTPA 1 donafenib 1 carmofur 1 camrelizumab 1 atezolizumab 1 apatinib 1 anlotinib 1 Yttrium-90 1 Whole Genome Sequencing 1 Watchful Waiting 1 Walking Speed 1 User-Centered Design 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04954521 2021-07-08

AFHC

People's Hospital of Guangxi Zhuang Autonomous Region

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡